Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 38.50 GBp
Change Today 0.00 / 0.00%
Volume 2.7K
As of 7:19 AM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Daniel W. Elger BA, Ph.D.

Former Chief Financial Officer and Director, e-Therapeutics plc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 3 different industries.

45216,000 GBP
As of Fiscal Year 2015

Background*

Dr. Daniel W. Elger, BA, PhD served as Chief Financial and Corporate Development Officer at GenKyoTex S.A. since June 2014. Dr. Elger served as the Chief Financial Officer of e-Therapeutics Plc. since from 13, 2011 to April 7, 2014. Dr. Elger joined e-Therapeutics in June 2011. He served as a Vice President of Marketing & Communications of Sarossa Plc (also known as Antisoma PLC) since 2008, Director of Communications since April 2005, Vice President of Marketing & Communications ...

Read Full Background

Corporate Headquarters*

Network Pharmacology Centre
Long Hanborough, Oxfordshire OX29 8LN

United Kingdom

Phone: 44 1993 880 000
Fax: 44 1993 880 207

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

PhD
University of Oxford
BA
University of Oxford

Other Affiliations*

Annual Compensation*

Salary196,000 GBP
Total Annual Compensation196,000 GBP

Stock Options*

All Other Compensation20,000 GBP
Unexercisable Options351,387
Unexercisable Options Value108,579 GBP
Total Value of Options108,578 GBP
Total Number of Options351,387

Total Compensation*

Total Annual Cash Compensation216,000 GBP
Total Short Term Compensation196,000 GBP
Other Long Term Compensation20,000 GBP
Total Calculated Compensation216,000 GBP
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ETX:LN 38.50 GBp 0.00

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact E-THERAPEUTICS PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.